| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

Novadoz/MSN Labs Receives FDA Clearance for Fosaprepitant, Decitabine

Increase font size  Decrease font size Date:2019-09-10   Views:34

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approvals for their generic versions of Decitabine and Fosaprepitant for injection. The company has immediately commenced shipping of Fosaprepitant, which coincides with the first day of patent expiration for the brand EMEND©, marketed by Merck. Novadoz expects to begin the shipping of Decitabine, their generic version of DACOGEN© from Otsuka, later this month.

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028